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Abstract
Background: Centrioles are microtubule-based cylindrical structures composed of nine triplet tubules and are required for
the formation of the centrosome, flagella and cilia. Despite theirs importance, centriole biogenesis is poorly understood.
Centrosome duplication is initiated at the G1/S transition by the sequential recruitment of a set of conserved proteins under
the control of the kinase Plk4. Subsequently, the procentriole is assembled by the polymerization of centriolar tubules via an
unknown mechanism involving several tubulin paralogs.
Methodology/Principal Findings: Here, we developed a cellular assay to study centrosome duplication and procentriole
stability based on its sensitivity to the microtubule-depolymerizing drug nocodazole. By using RNA interference
experiments, we show that the stability of growing procentrioles is regulated by the microtubule-stabilizing protein
CAP350, independently of hSAS-6 and CPAP which initiate procentriole growth. Furthermore, our analysis reveals the critical
role of centriolar tubule stability for an efficient procentriole growth.
Conclusions/Significance: CAP350 belongs to a new class of proteins which associate and stabilize centriolar tubules to
control centriole duplication.
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Introduction
Centrioles are required for the formation of the centrosome,
flagella and cilia and are microtubule-based cylindrical structures
that exhibit nine triplet tubules arranged around a nine-fold
symetry carthweel structure [1]. The centrosome is the main
microtubule organizing center in animal cells and is composed of a
pair of centrioles surrounded by pericentriolar material. Despite its
importance, the biogenesis of centriole is a poorly understood
process. The centrosome duplication is initiated at the G1/S
transition by the sequential recruitment of a set of conserved
proteins under the control of Plk-4 and the related kinase Zyg-1 in
C.elegans [2–5]. Using a centriole overduplication assay based on
Plk-4 overexpression, we have previously proposed that in human
cells hSAS-6, Cep135 and CPAP form a seed for the intiation of
centriole growth [3]. Recently, in C.elegans a model for the
elongation of centriolar tubules mediated by SAS-4 (homolog of
CPAP) along a central tube formed by SAS-6 was proposed [6].
Subsequently, the procentriole is assembled by the polymerization
of the first centriolar tubule named tubule A followed by the
growth of the centriolar tubules B and C via an unknown
mechanism involving several tubulin paralogs [7]. In spite of
recent advances, the regulation of the centriolar tubule growth
remains unknown. To monitor centrosome duplication in
mammalian cells several assays based on the the formation of
mutiple centrioles were developped. However, the centriole
elongation process can not be analyzed with these assays. To this
end we developped a new approach using synchronized RPE-1
cells and a microtubule-poisoning drug to reveal the role of
CAP305 during centriolar tubule growth.
Results
Sensitivity of centriole growth to nocodazole
Centriole growth requires the addition of tubulin dimers or
polymers to centriolar microtubules. The mechanism for the
centriolar tubule polymerization is unknown but may share some
similarities with microtubule growth. The effect of microtubule-
poisoning drugs on centrosome duplication has not been tested in
detail. It has been previously reported that colcemid treated cells
have shorter daughter centrioles, although centriole initiation
remains unaffected [8]. However, at a higher concentration,
colcemid inhibits the initiation of centriole growth. More recently,
centrosome overduplication in CHO cells has also been shown to
be sensitive to nocodazole [9]. Alltogether, these results showed
that depending on the concentration used, a microtubule-
disrupting drug can either inhibits centriole elongation or block
the initiation of centriole growth. To confirm and further detail the
effect of a microtubule-poisoning drug on the centriole growth, we
tested the effect of nocodazole on centrosome overduplication
induced by Plk4 overexpression in S phase at a concentration that
disrupts the microtubule network (Figure 1A). In order to have a
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pression, we quantified the number of newly formed procentrioles
per mother centriole. Indeed, the inducible expression of Plk4 in a
U2OS/plk4 cell line results in the accumulation of Plk4 at the
parental centriole which drives the formation of variable numbers
of centrioles ranging from 2 to 9 as indicated by the staining of the
centriolar marker centrin-2 [3](Figure S1A). The induction of Plk4
overexpression promotes the accumulation of centrosome proteins
such as hSAS-6, CPAP, CP110 or Centrin-2 at the parental
centriole forming a ring or a halo initiating the sprouting of
procentrioles (Figures 1B and S1B). Consistent with previous work,
application of nocodazole during the centriole overduplication
decreased the proportion of cells with more than three
procentrioles when compared to the control cells (Figure 1C).
Concomitantly, the proportion of cells with no or one procentriole
increased. Interestingly, mother centrioles without daughter
centriole still recruited Plk4, and the formation of a halo as
indicated by the accumulation of Centrin-2 was still apparent
suggesting that while the initial events of the centriole duplication
take place in the presence of nocodazole, procentriole growth may
be defective (Figure 1D). The disruption of the microtubule
network by nocodazole is unlikely to be responsible for this
inhibition because the inactivation of the dynein mediated
transport by a dominant negative approach has no effect on
centrosome duplication [10]. Thus, these observations suggest that
nocodazole may directly inhibit centriole overduplication by
blocking the growth of centriolar tubules. Our previous work
showed that the growth of procentrioles start between 6 and
16 hours after induction of Plk4 [3]. To determine whether
nocodazole depolymerizes centriolar tubules, we added the drug
12 hours after the induction of Plk4 to allow for the initiation of
centriolar tubule growth. Surprinsingly, drug addition at this stage
had no effect on centriole overduplication indicating that the
nocodazole did not depolymerize centriolar tubules (figure 1C).
Together with the observation that nocodazole inhibits centriole
duplication, our results indicate that nocodazole inhibits the
polymerization of centriolar tubules early during the procentriole
assembly process.
We next tested the effect of nocodazole during the normal one-
round duplication of the centrosome in the same cell line. U2OS
cells in G1 were treated with nocodazole and the duplication state
of the centrosome were analysed 15 hours later by staining the
Figure 1. Nocodazole blocks centriole duplication at an early stage. (A) DMSO and nocodazole treated U2OS cells were stained with an
antibody against a-tubulin. (B) Myc-Plk4 expression was induced for 3 hr in S-phase arrest U2OS cells and stained for Centrin (green) and Myc (9E10)
(red) to illustrate a typical halo without new procentrioles. Note the presence of two parental centrioles. (C and D) Cells were treated with nocodazole
(3.3 mM) simultaneously or 12 hr after the induction of Myc-Plk4. Control cells were treated with the vehicule DMSO (n=3, ,50 cells per condition).
(C) Procentrioles were visualized using an anti-centrin staining and counted. The histogramm shows the number of procentrioles surrounding a
parental centriole. Error bars represent SE. (D) The panel C shows the negative effect of nocodazole on procentriole assembly as visualized with
centrin (green) and Myc (red) staining. Note that multiple procentrioles are arranged in a flower-like structure around the parental centriole in control
cells. (E) U2OS cells were synchronized in mitosis with 25 mM noscapine and release for 3 hr before nocodazole (3.3 mM) treatment. The number of
centriole was quantified using an anti-CP110 antibody 15 hr after nocodazole addition to the medium. Cells with unduplicated centrosomes exibit 2
CP110 dots staining 2 mother centrioles whereas cells with duplicated centrosomes exhibit 4 CP110 dots staining for 2 mother and 2 daughter
centrioles. Error bars represent SE.
doi:10.1371/journal.pone.0003855.g001
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growing procentrioles [11]. The addition of the microtubule-
disruptive drug did not inhibit the percentage of cells with four
centrioles when compared to the control (Figure 1E). In agreement
with previous work, our data showed that a microtubule-
depolymerizing drug does not inhibit the initiation of the centriole
growth and also reveals that the centriole overduplication process
is more sensitive to nocodazole than the one-round centriole
duplication. Given the different sensitivity to nocodazole in the
two conditions, we propose that the centriole growth machinery
during centriole overduplication is an exhausted system generating
less stable procentrioles sensitive to microtubule-depolymerizing
drugs. Furthermore, this result establishes that the polymerization
of centriolar tubules is a robust process resistant to nocodazole and
highlights the stability of growing centriolar tubule with respect to
cytoplasmic microtubules. This raises the question of what controls
procentriole stability during centrosome duplication.
A cellular model for studying centrosome duplication
All mammalian cellular systems established to study centrosome
duplication involve non-physiological stimulation of centrosome
overduplication in transformed cell lines [3,12]. Therefore, to
answer the question how procentriole stability is regulated, a new
cellular model needed to be developed to study the centrosome
duplication in a non-transformed cell line under physiological
conditions. The immortalized human cell line RPE-1 was choosen
since it can easily be synchronized in G0 by 48 hr-serum
starvation. In addition, the disruption of the microtubule network
has no consequence on the cell cycle progression until M phase in
these cells [13]. The duplication of the centrosome started in late
G1 and proceeds during S, G2 and M phases [14]. The costaining
of the centrosome with hSAS-6, a daugther centriole specific
marker, and CP110 revealed that centriole duplication is initiated
by the recruitment of hSAS-6 at both parental centrioles 15 hours
after serum stimulation (Figure S2A and S2B). In S phase, the
presence of three or four CP110 dots indicates that centriole
elongation is in progress (Figure S2C).
The microtubule binding protein CAP350 regulates
procentriole stability
Having established the cellular model, we then investigated the
regulation of procentriole stability by testing the sensitivity of
centriole biogenesis in RPE-1 cells to nocodazole after the
depletion of potential factors. We focused our attention to
CAP350 and FOP because they habor specific domains known
to be involved in microtubule dynamics, a CAP-Gly domain and a
LisH domain respectively. We have recently demonstrated that the
centrosomal protein CAP350 recruits FOP to form a complex
regulating microtubule anchoring [15]. Interestingly, CAP350 has
been shown to stabilize microtubules via several microtubule
binding domains suggesting that it could also stabilize centriolar
tubules since CAP350 is associated with centrioles [16]. These
features prompted us to investigate the role of this complex during
centriole duplication initiation and elongation in RPE-1 cells by
RNA interference experiments and nocodazole treatment. The
duplication of the centrosome was monitored in S phase 21 hours
after serum addition using an antibody targeting CP110. First,
CAP350 and FOP depletion were assayed by immunofluorescence
(Figure 2A). As previously reported [15], FOP depletion had no
effect on CAP350 localization however CAP350 depletion
delocalized FOP from the centrosome. As a control, we knocked
down SAS-6 expression to prevent centrosome duplication and
observed no effect on CAP350 and FOP localization (Figure 2A).
Interestingly, the depletion of CAP350 and FOP had no
consequence on the recruitment of SAS-6 at the centrosome
indicating that they are not required for the initiation of the
duplication of the centrosome (Figure 2A). As shown in the
figure 2B, nocodazole had no effect on centrosome duplication in
RPE-1 cells at a concentration disrupting cytoplasmic microtu-
bules confirming that centriole duplication is resistant to
nocodazole. Next, the effect of nocodazole on centriole duplication
was compared after the knock down of CAP350 and FOP
expression to the Gl2 control. We were unable to directly assess
protein levels because CAP350 is not sufficiently abundant to be
detected. Therefore, CAP350 and FOP depletion were checked by
immunofluorescence. In the absence of nocodazole, CAP350
depletion had an effect on centrosome duplication while FOP had
no effect. The addition of nocodazole strongly inhibited centriole
duplication after CAP350 depletion but not after FOP depletion
(Figure 2B). Thus, in contrast to FOP depletion, the knock down of
CAP350 sensitized centriole duplication to nocodazole suggesting
that CAP350 regulates procentriole stability independently of
FOP. This result was validated by a second CAP350 specific
siRNA (data not shown). To rule out a non-specific effect of the
CAP350 depletion on the G1/S transition, levels of the late-S-
phase-induced marker Cyclin B1 were measured by Western blot.
The similar abundance of Cyclin B1 indicated that the cell cycle
progress normaly in CAP350-depleted cells (Figure S3A).
Additionaly, to investigate the specificity of nocodazole on
centriole growth, we compared the proportion of cells positive
for hSAS-6 with or without nocodazole as an indicator of the
initiation of centriole duplication. The ratio of hSAS-6 positive
cells between CAP350-depleted and Gl2 control cells remained
unchanged after treatment demonstrating that when CAP350
protein levels are reduced, nocodazole inhibits specifically the
growth of procentrioles but not the initiation of centriole
duplication (Figure S3B). Note that the percentage of hSAS-6
positive cells is slightly lower in CAP350 depleted cells compared
to the control, but as discussed below, a lower amount of hSAS-6
does not sensitize the centrosome duplication process to
nocodazole.
As shown in the figure 1B, nocodazole interfered with
procentriole growth at an early stage. Hence, the role of
CAP350 later during procentriole elongation remains an open
question. As mentioned before, the elongation of the centrioles
proceeds during G2 and M phases. Therefore, we examined the
stability of the growing centriole at the S/G2 transition which
takes place between 24 and 30 hours after serum stimulation (data
not shown). To this end, we treated the cells with nocodazole
24 hours after serum stimulation for 1 hour and quantified the
number of duplicated centrosomes in control and CAP350
depleted cells. We found that nocodazole did not destabilize
growing centrioles suggesting that CAP350 is not required for
stabilizing growing centrioles in S/G2 (Figure 2C). Collectively,
our data demonstrate that CAP350 has a centriolar tubule-
stabilizing activity in growing procentrioles at an early stage of
procentriole assembly.
hSAS-6 and CPAP do not protect centriolar tubules
against nocodazole
Having established that CAP350 stabilizes procentrioles early in
the assembly pathway of a new centrioles, we investigated whether
the centriole duplication initiation process contribute to procen-
triole stability. Indeed, in the C.elegans model, hSAS-6 was
proposed to form a tube allowing the SAS-4-mediated polymer-
ization of the centriolar tubules along its lenght [6,17]. Since the
centrosome duplication machinery is conserved between species,
hSAS-6 and CPAP, the human SAS-4 ortholog, could potentially
Stability of the Procentriole
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stabilization. In agreement with our previous finding [3], SAS-6
recruitment is dependent on CPAP as revealed by the lower
abundance of hSAS-6 at the centrosome in CPAP depleted cells
(Figure 3A). Additionally, we observed that the CPAP signal in
hSAS-6 depleted cells is also slightly reduced showing that both
proteins are interdependent. However, since CPAP is present at
the centrosome before SAS-6 recruitment, a pool of CPAP is not
dependent on hSAS-6 (data not shown). Therefore, this fraction of
CPAP localizes probably to the pericentriolar region and when the
centrosome duplication is initiated by hSAS-6, CPAP is recruited
at the procentriole [18]. To address the role of these initiator
proteins in the procentriole stability, we performed the procen-
triole stability assay described in the previous section after the
partial depletion of hSAS-6 and CPAP by RNAi. Indeed a strong
depletion of hSAS-6 or CPAP reduces severely centrosome
duplication impeding the ability to analyse the centriole growth
sensitivity to nocodazole (data not shown). Delivery of siRNA to
cells decreased the level of SAS-6 and CPAP (Figure 3B).
Confirming their role for the initiation of centriole growth,
centrosome duplication was impaired following hSAS-6 and
CPAP partial depletions. However in contrast to CAP350
depletion, the duplication of the centriole was still resistant to
nocodazole treatment suggesting that they do not protect
centriolar microtubules to nocodazole (Figure 3C). Hence,
knowing that hSAS-6 and CPAP are thought to promote centriole
elongation, our data indicate that hSAS6/CPAP do not stabilize
the procentriole independently of their procentriole growth
Figure 2. CAP350 protects centriolar tubules against the microtubule-depolymerizing activity of nocodazole. (A, B, C) RPE-1 cells were
transfected for 24 hr with siRNA duplexes targeting CAP350, FOP, hSAS-6 or Gl2 for control. Then cells were starved for 48 hr before inducing the
reentry into the cell cycle with a serum stimulation. Cells were processed for immunofluorescence microscopy 21 hr after serum addition, using the
antibodies indicated and DAPI (blue). (B) siRNA transfected RPE-1 cells in G1 phase were treated with nocodazole (3.3 mM) or DMSO 12 hr after serum
stimulation. The number of centriole was quantified using an anti-CP110 antibody 21 hr after serum addition. Cells with duplicated centrosomes
exhibit 3 or 4 CP110 dots, (n=3, ,50 cells per condition). Error bars represent SE (right panel). DMSO and nocodazole treated RPE-1 cells were stained
with an antibody against a-tubulin (left panel) (C) siRNA transfected RPE-1 cells in S/G2 phase were treated with nocodazole or DMSO 24 hr after
serum stimulation for 1 hr. The number of centriole was quantified using an anti-CP110 antibody. Cells with duplicated centrosomes exhibit 3 or 4
CP110 dots, (n=3, ,50 cells per condition). Error bars represent SE.
doi:10.1371/journal.pone.0003855.g002
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nocodazole observed after CAP350 depletion is specific because
defective initiation of centriole biogenesis did not sensitize the
duplication process to this microtubule-depolymerizing drug.
Procentriole stability is required for centriole growth
Our experiments demonstrate that CAP350 participates in a
pathway stabilizing growing centriolar tubules. However, the
depletion of CAP350 had no major effect on the duplication of the
centrosome suggesting that either the stability of the procentriole is
not essential for its growth or that some redundancy compensates
the lack of CAP350. To address this question we investigated the
consequence of CAP350 depletion on centriole overduplication in
the Plk4-induced centriole overduplication assay. Since the
centriole overproduction system generates less stable centrioles,
we reasoned that the depletion of a protein involved in
procentriole stability should reveal whether it is required for
centriole growth or not. After Plk4 induction, CAP350 was
associated with growing centrioles and the pericentriolar material
as revealed by immunofluorescence (Figures 4A and 4B). As
previously demonstrated, Plk4 induction promotes the accumula-
tion of centrosomal proteins such as hSAS-6 and CPAP around
the mother centriole [3]. These proteins form a ring or a halo
structure promoting the growth of centrioles and the recruitment
of CP110. In the absence of CAP350, both hSAS-6 and CP110
were localized around the mother centriole indicating that the
initial events leading to centriole growth were not defective after
CAP350 depletion in agreement with our observations in RPE-1
cells (Figure 4A and 4B). However, immunostaining indicated that
CP110 positive structures differed between the control and
CAP350 depleted cells. In CAP350 depleted cells, the CP110
staining formed a ring or a halo without distinctive dots suggesting
that centriole growth is defective. Indeed, the growth of
procentrioles enlarges the CP110 ring which at a critical size will
form distinct CP110 dots at the distal tip of the newly formed
procentrioles (Figure S1B). To validate this observation, we
quantified the number of additional procentrioles produced after
Plk4 overexpression in CAP350 and FOP depleted cells. As we
were unable to directly assess CAP350 protein levels, protein
depletion were checked by immunofluorescence. Whereas 42% of
cells treated with the control siRNA had more than 3 procentrioles
per mother centriole, only 10% of cells treated with the CAP350
siRNA showed efficient centriole overduplication (Figure 4C). As
expected, the production of additional centrioles per mother
centriole was not altered by FOP depletion. In this system, the
depletion of CAP350 did not affect the percentage of SAS-6 or
Figure 3. hSAS-6 and CPAP do not protect centriolar tubules against nocodazole. (A) RPE-1 cells were treated as described in the legend to
Figure 2, using siRNA duplexes targeting hSAS-6, CPAP or Gl2 for control. Costaining were performed using anti-hSAS-6 (green), anti-CPAP (red) and
DAPI (blue). (B and C) siRNA transfected RPE-1 cells in G1 phase were treated with nocodazole (3.3 mM) or DMSO 12 hr after serum stimulation before
the recruitment of SAS-6. (B) Western blot on RPE-1 cells illustrating the partial depletion of hSAS-6 and CPAP by siRNA.(C) The number of centriole
was quantified using an anti-CP110 antibody 21 hr after serum addition. Cells with duplicated centrosomes exhibit 3 or 4 CP110 dots, (n=3, ,50 cells
per condition). Error bars represent SE.
doi:10.1371/journal.pone.0003855.g003
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observations confirmed the requirement of CAP350 during
centriole elongation and demonstrate that the centriole stability
is required for centriole growth.
Discussion
How centriole and basal bodies are assembled constitutes a long-
standing unresolved question. Our findings provide evidence that
centriole growth is regulated by the centriolar tubule-stabilizing
activity of CAP350. The formation of a procentriolar ‘‘seed’’,
constituted notably by hSAS-6 and CPAP, promotes the assembly
of a nascent procentiole under the control of Plk4 [3]. The
stabilizing function of CAP350 is required early during the
procentriole assembly process presumably when the first microtu-
bule are polymerized. SAS-6 and CPAP control the polymerization
of centriolar tubules independently of CAP350. Nonetheless,
because hSAS-6 and CPAP are required for the initiation of
centrosome duplication, their potential role in the stability of the
procentriole cannot be totaly ruled out. Indeed, our assay cannot
determine whether hSAS6 and/or CPAP have a potential coupled-
microtubule stabilization/polymerization activity similar to some
XMAP225/TOG family members. Therefore, we can only
conclude that they do not function as a mere Microtubule
Associated Protein likeCAP350 (see below). Additional experiments
are required to decipher the biochemical activity of hSAS-6 and
CPAP. Finally, our data showed that the centriole overduplication
system is less robust than the one-round centrosome duplication
system which indicates that results obtained using centrosome
overduplication systems should be analyzed with cautious.
A key question concerns the basis of the procentriolar stability
mediated by CAP350. CAP350 localizes to the centriole and the
pericentriolar material [15,16]. Ultrastructural studies by electron
microscopy were unsuccessful in revealing a specific signal for
CAP350. However the CAP350 interactor FOP was successfully
stained. FOP decorates centriolar tubule blades and knowing that
CAP350 recruits FOP to the centrosome, we presumed that
CAP350 interacts with centriolar blades (data not shown). By
analogy to axon growth in neuron cells, CAP350 may function as
a centriolar tubule-binding protein stabilizing the growing
procentriole through a direct interaction via its multiple
microtubule binding domains.
The highly stable nature of a centriole is conferred by the
polyglutamylation of tubulins [19]. The polyglutamylation occurs
during centriole elongation in G2/M phase when the tubulin
polyglutamylaseactivityis high,makingcentrioleshighlyresistant to
microtubule-depolymerizing drugs [3,20]. However, we demon-
strated that nocodazole does not depolymerize centriolar tubules
induced by the overexpression of Plk4 in U2OS cells arrested in S
phase suggesting that additional mechanisms regulate centriolar
stability. This is consistent with the nocodazole resistance of the
procentrioles in the absence of CAP350 in late S phase.
Microtubule depolymerization occurs by increased curvature of
the end of protofilaments in the microtubule following GTP
hydrolysis. Given the organization of the centriolar triplets, it is
tempting to speculate that the close association of the centriolar
tubules could prevent the microtubule peeling and protect them
against a microtubule destabilizer such as nocodazole. The
polymerization of tubules B and C requires e-tubulin and d-
tubulin as revealed by the analysis of Paramecium and Chlamydomonas
mutants [7,21,22]. In agreement with our hypothesis, these studies
have suggested that the microtubule triplet function was to
stabilize the centriole. Therefore, we propose the following model
describing procentriole assembly. The formation of a ‘‘seed’’
constituted in part by hSAS6 and CPAP promote the initiation of
the growth of the centriolar tubule A. At the onset of procentriole
growth, microtubule stabilizing proteins such as CAP350 stabilizes
the centriolar tubule A before the polymerization of the centriolar
Figure 4. Stable centriolar tubules is required for the biogenesis of multiple procentrioles. (A and B) U2OS cells were transfected for
75 hr with siRNA duplexes targeting CAP350 and Gl2 for control. Then, Myc-Plk4 was induced for 21 hr in the continued presence of siRNA duplexes,
and cells were processed for immunofluorescence microscopy using the antibodies indicated. (C) U2OS cells were transfected with siRNA duplexes
targeting CAP350, FOP or Gl2 for control. Procentrioles were visualized using an anti-centrin staining and counted. The histogramm shows the
number of procentrioles surrounding a parental centriole, (n=3, ,50 cells per condition). Error bars represent SE.
doi:10.1371/journal.pone.0003855.g004
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interaction with other centriolar tubule binding proteins. This
model provide an explanation of the early requirement of CAP350
and suggest that the assembly of the first centriolar tubule could be
a critical step for the regulation of centriole duplication.
Our results demonstrate that unstable procentrioles fail to grow.
This indicates that similarly to growing microtubule-based
structures such as axons or cilia, centriolar tubules could grow
and shrink under the control of external factors. Indeed, the
recently reported centrosome inventory revealed several factors
with potential centriolar-destabilizing activity [23]. Of particular
interest are the microtubule severing enzymes such as Katanin or
the microtubule-destabilizing Kinesins which are both known to
regulate the flagellum length [24,25].
Despite its potential importance for cancer progression, the
question how structural anomalies appear in centrioles has not
previously been adressed. In this study, we established the crucial
role of stabilizing factors for normal procentriole assembly. The
increased sensitivity of centriole overduplication to a microtubule-
disrupting drug indicates that uncontrolled centrosome duplication
may generate aberrant centriolar structures in cancer cells, either
because of an altered centriolar tubule stabilizing pathway or by
an increased expression of centriolar destabilizing factors.
Consistent with this hypothesis, application of high concentrations
of vinblastine generates daughter centrioles with aberrant
structures reminiscent of what is observed in cancer cells [26–
28]. A better understanding of the regulation of procentriole
stability may shed some light on the role of centrosome
abnormalities during cancer progression.
Materials and Methods
Antibodies
Rabbit polyclonal antibody was raised at Charles Rivers
laboratories (Elevages Scientifique des Dombes, Charles River
laboratories, Romans, France) against GST-CP110 (aa 1–149) and
then purified according to standard purification. Rabbit anti-
CAP350, anti-FOP, anti-CPAP and anti-centrin-2 were previously
described [3] and antibody against a-tubulin and acetyl-tubulin
were purchased from Sigma (Taufkirchen, Germany). The
monoclonal antibodies against hSAS-6 and CPAP were previously
described [3].
Cell Culture and transfection
U2OS and the U2OS/plk4 cell line were cultured as described
previously [3]. hTERT-RPE1 cells were grown in DME nutrient
mixture, Ham’s F12 (Sigma-Aldrich) supplemented with 10%
FCS, penicillin-streptomycin, 2 mM glutamine, and 0.348%
sodium bicarbonate. siRNA transfections were performed using
Oligofectamin (Life Technologies, Karlsruhe, Germany).
siRNA experiments and procentriole stability assay
CAP350, FOP, CPAP and hSAS-6 were depleted using siRNA
duplex oligonucleotides (Qiagen and Dharmacon) targeting the
sequences described previously [3,15]. A duplex targeting
luciferase (GL2) was used for control [3]. RNA oligonucleotides
were used at 200 nM, except for the partial depletion of hSAS-6
and CPAP where 100 nM of siRNA were used. hTERT-RPE1
cells (provided by L. Kohen, Universia ¨tsklinikum Leipzig, Leipzig,
Germany) were grown on acid-treated, sterilized glass coverslips
and transfected for 24 h with different siRNA duplexes. Go state
was induced in confluent cells by continued culturing in serum-free
medium for another 48 h. Cell cycle reentry was induced by 10%
FCS addition. 12 hr after serum stimulation, cells were incubated
for 9 hr with 3.3 mM nocodazole.
Microscopic techniques
Cells were prepared for immunofluorescence as previously
described [3]. RPE-1 cells were analysed using a microscope
(Axioskop; Carl Zeiss Microimaging, Inc.) equipped with a 636
NA 1.4 plan apochromat oil-immersion objective and standard
filter sets, a 1,30061,300 pixel cooled charge-coupled device
camera (CCD-1300-Y; Princeton Instruments), and Metavue
software (visitron Systems). Alternatively, centriole overduplication
in the U2OS/Plk4 cell line were analysed using a Deltavision
microscope on a Nikon TE200 base (Applied Precision, Issaquah,
WA) equipped with a APOPLAN 6100 NA 1.4 plan oil-
immersion objective. Serial optical sections obtained 0.3 mm apart
along the Z-axis were processed using Softworx (Applied
Precision).
Supporting Information
Figure S1 Plk4-induced centriole biogenesis (A and B) U2OS
cells were treated as indicated in the legend Figure 1. (A)
Centrosome was stained with anti-centrin (green) to visualize
centrioles and anti-hSAS6 (red) which accumulates around the
mother centriole. (B) Myc-Plk4 expression was induced for 3 hr
and 24 hr. Centrosome was stained with Myc 9E10 (green) and
anti-CP110 (red). At 3 hr, no flower-like structure is observed
hence, CP110 is accumulated around the MycPlk4 signal forming
an outer ring. At 24 hr, the CP110 staining is organized like a
flower-like structure revealing that procentrioles are growing.
Found at: doi:10.1371/journal.pone.0003855.s001 (0.94 MB TIF)
Figure S2 Description of centrosome duplication in RPE-1 cells
using centriolar markers. (A and B) RPE-1 were synchronized in
G0 by serum starvation and then restimulated with 10% serum.
Centrioles were stained with an anti-hSAS-6 (green) and anti-
CP110 (red) and DNA was stained with DAPI (blue) at different
time points. (A) the panel A shows all hSAS-6 and CP110 staining
patterns observed. Note that cells with 3 or 4 CP110 dots harbor
separated centrosomes for an easier visualisation of the centrioles.
(B) The different hSAS-6 and CP110 staining patterns were
quantified for each indicated time points (100 cells counted at each
time points). (C) Centrioles was stained with anti-acetyl-tubulin
(green) to visualize the cilium and with an anti-CP110 (red). DNA
was stained with DAPI. Note that separated centrosomes indicate
that the cells are in G2 and that cells with three CP110 dots still
exibit a cilium preventing the recruitment of CP110.
Found at: doi:10.1371/journal.pone.0003855.s002 (1.16 MB TIF)
Figure S3 Nocodazole inhibits specificaly centriolar tubule
growth. RPE-1 cells were treated as indicated in the legend
figure 2. (A) Total cell lysates from CAP350-depleted or control
cells were collected 21 hours after serum stimulation and probed
using the antibodies indicated. Cep135 levels provide a loading
control. (B) SAS-6 positive cells were quantified in Gl2 and
CAP350-depleted cells. The histogramm shows the ratio
CAP350/Gl2 in control and nocodazole treated cells. In control
and nocodazole treated cells, the ratio is ,1 due to a lower
abundance of SAS-6 in CAP350, (n=3, ,50 cells per condition).
Error bars represent SE.
Found at: doi:10.1371/journal.pone.0003855.s003 (0.81 MB TIF)
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